Computerized Thermal Imaging has sold 10 breast-imaging systems for $5 million to a Latin American consortium based in Mexico City. The consortium, Computerized Thermal Imaging International, and CTI have a goal of selling 100 breast imaging systems in
Computerized Thermal Imaging has sold 10 breast-imaging systems for $5 million to a Latin American consortium based in Mexico City. The consortium, Computerized Thermal Imaging International, and CTI have a goal of selling 100 breast imaging systems in Latin America.
The CTI system, which has not been approved in the U.S., consists of a patient table and heat-sensitive camera, and can be used in conjunction with traditional x-ray mammography, the firm said. CTIs technology takes an image based on heat radiating from the body.
The company believes that data generated by the CTI system can assist physicians in detecting the presence of numerous diseases, disorders, and injuries that conventional imaging such as x-ray, CT, or MR may miss.
The approval process in Mexico is less stringent than in the U.S., said John Ott, CTIs senior vice president of marketing and business development.
Since theres no radiation involved, it (the approval process) is easier, Ott said. Its region by region and hospital by hospital. They do their evaluation based on clinical trials and early results.
David Packer, CTI president and COO, said this is the first sale of his companys system. CTI is seeking FDA premarket approval for its Computerized Thermal Imaging system in the U.S.
The company announced last week that it had received approval of Module 2 of its application, which was submitted in February. There are five modules, data packages describing how the imaging system works (SCAN, 5/24/00). Module 1 was approved in December 1999 (SCAN, 1/12/00).
Module 2 contains system design information and is the most technologically complex of all the modules, Packer said.
The Latin American consortium, CTII, is owned in part by CTI, the imaging company.
Its not our endeavor, Ott said. We own 15%. The name similarity is a blessing and a curseit gives us name recognition to the casual observer, but it also looks like were selling equipment to ourselves.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.